1Danzi GB, Sesana M, Capuano C, et al. Long-term clinical outcomes after coronary angioplasty using long stents in small coronary vessels. Catheter Cardiovasc Interv, 2002,56:300-304.
2Shen WF, Zhang RY, Shen Y, et al. Optimal timing for coronary stenting in unstable angina. Chin Med J, 2001,114:59-61.
3Thomas JR, Wiliam jBB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty. Circulation,1993,88:2987-3006.
4Serruys PW, De JP, Kiemenij F, et al. For the Benestent study group. A comparison of balloon-expandable stent implicatation with balloon angioplasty in patients with coronary artery disease. N Engl J Med,1994,331:489-495.
5Yoshitomi Y, Kojima S, Yano M, et al. Does stent design affect probability of restenosis? A randomized trial comparing multilink stents with GFX stents. Am Heart J, 2001,142:445-451.
2[1]Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult--summary article[J].Circulation,2005,112(12):1825-1852.
3[2]Khand A,Gemmel I,Clark A,et al.Is the prognosis of heart failure improving?[J].J Am Coll Cardiol,2000,36(7):2284-2286.
4[3]Cleland JG,Swedberg K,Follath F,et al.The Euro Heart Failure survey programme:survey on the quality of care among patients with heart failure in Europe.Part I:patient characteristics and diagnosis[J].Eur Heart J,2003,24(5):442-463.
5[4]He J,Gu D,Wu X,et al.Major causes of death among men and women in China[J].N Engl J Med,2005;353(11):1124-1134.
6[6]Sliwa K,Woodiwiss A,Kone VN,et al.Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline.Results of a randomized study[J].Circulation,2004,109(6):750-755.
7[7]Rizzello V,Poldermans D,Boersma E,et al.Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy.Role of myocardial viability[J].Circulation,2004,110(16):2383-2388.
8[8]Chareonthaitawee P,Gersh B,Araoz PA,et al.Revascularization in severe left ventricular dysfunction.The role of viability testing[J].J Am Coll Cardiol,2005,46(4):567-574.
9[9]Knuuti J,Schelbert HR,Bax JJ.The need for standardization of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischemic left ventricular dysfunction[J].Eur J Nucl Med Imaging,2002,29(9):1257-1266.
10[10]Zoghbi WA.Evaluation of myocardial viability with contrast echocardiography[J].Am J Cardiol,2002,90(10A):65J~71J.
